Evidence-based information on
peptides and SARMs,
all in one place.
Every compound profile is grounded in peer-reviewed research from NIH, PubMed, and FDA filings. No hype. No pseudoscience. Just structured, plain-English summaries of what the literature actually says.
21+ compound profiles · Sources: NIH, PubMed, FDA, ClinicalTrials.gov
Credible Sources
Every claim is tied to published research. We cite PubMed IDs, clinical trial registrations, and FDA documents — not forums or anecdote.
Structured Profiles
Each compound profile covers mechanism, evidence level, dosing research, benefits, side effects, and regulatory status in a consistent format.
Plain-English Summaries
We translate dense scientific literature into accessible language without oversimplifying the nuance that actually matters for safety and efficacy.
Safety-Focused Approach
We prominently note when evidence is limited, when compounds carry known risks, and where regulatory agencies have raised concerns. We don't sugarcoat.
Compound Library
Structured profiles for the most-researched peptides and SARMs.
BPC-157
BPC-157 (Body Protective Compound-157) is a pentadecapeptide derived from a protective protein found in human gastric juice. It has demonstrated remarkable tiss…
Read Profile →TB-500
TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4 (Tβ4), a naturally occurring protein present in virtually all human and animal cells. It pla…
Read Profile →GHK-Cu
GHK-Cu (Glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper peptide found in human plasma, saliva, and urine. Its plasma concentration declines s…
Read Profile →Ipamorelin
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. It is one of the most studied GH-releasing peptides due to its high selectiv…
Read Profile →CJC-1295
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) with an extended half-life. The DAC (Drug Affinity Complex) version binds to albumin…
Read Profile →Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management. It gained widespread recognition as Ozemp…
Read Profile →Peptide Research
Explore healing peptides, growth hormone secretagogues, GLP-1 agonists, cognitive enhancers, and longevity compounds. Covers BPC-157, Semaglutide, Ipamorelin, Semax, Epithalon, and more.
Explore Peptides →SARM Research
Selective androgen receptor modulators — Ostarine, Ligandrol, RAD-140, and more. Evidence levels, clinical trial status, suppression profiles, and safety data all in one place.
Explore SARMs →Injection Calculator
Enter your vial size, BAC water volume, and desired dose to calculate exactly how many units to draw. No spreadsheets needed.
Open Calculator →Research Blog
Plain-English breakdowns of the latest peptide and SARM research.
Understanding Peptide-Based Nootropics: Semax and Selank
Semax and Selank are Russian-developed neuropeptides with approval for clinical use in Russia and Ukraine. We review the published evidence, mechanisms, and what Western users should know.
Read article →The GLP-1 Revolution: Semaglutide, Tirzepatide, and What Comes Next
GLP-1 receptor agonists have transformed obesity medicine. We break down the mechanisms, the landmark trial data, and the emerging next generation of metabolic therapeutics.
Read article →BPC-157: What the Research Actually Says
A thorough review of the preclinical literature on BPC-157, why it's generated so much excitement in regenerative medicine circles, and what we don't yet know.
Read article →Join the Research Community
Discuss protocols, share research logs, ask questions, and engage with a community focused on evidence-based discussion.